TetraPhase Pharmaceuticals (NASDAQ:TTPH) discloses that it has received an unsolicited bid from La Jolla Pharmaceutical Company (NASDAQ:LJPC)
consisting of $22M in cash and an additional $12.5M payable via a
contingent value right (CVR). The board is considering the offer.
On March 26, it agreed to be acquired by AcelRx Pharmaceuticals (NASDAQ:ACRX) for ~$14.4M in an all-stock deal.
https://seekingalpha.com/news/3570959-la-jolla-pharma-makes-run-tetraphase-pharma
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.